Literature DB >> 24718527

[Validation of a liquid chromatography method for rifampicin determination in human plasma].

Luis Moreno-Exebio1, Miguel Grande-Ortiz1.   

Abstract

OBJECTIVES: To validate the high-performance liquid chromatography method (HPLC) for rifampicin (RFP) determination in human plasma.
MATERIALS AND METHODS: A HPLC method for RFP determination in plasma was developed. The separation was performed by reversed-phase chromatography with C18 column and a mobile phase composed of a mixture of acetonitrile and monobasic potassium phosphate buffer solution 0.05 M (38:62 v/v) at 335 nm in which standard rifampicin quinone (RFP-QN) was used.
RESULTS: The retention times of RFP and RFP-QN were 7.81 and 12.26 minutes, respectively. The trial was linear from 0.5 to 250 ug/mL. The evaluated parameters of precision, accuracy, selectivity, linearity, and recovery complied with the established international standards for validation of bioanalytical methods.
CONCLUSIONS: The developed HPLC method is simple, specific, sensitive, selective and linear for a wide range of RFP concentrations in plasma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24718527

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  2 in total

1.  Theoretically Guided Analytical Method Development and Validation for the Estimation of Rifampicin in a Mixture of Isoniazid and Pyrazinamide by UV Spectrophotometer.

Authors:  Mohammad F Khan; Shamima A Rita; Md Shahidulla Kayser; Md Shariful Islam; Sharmeen Asad; Ridwan Bin Rashid; Md Abdul Bari; Muhammed M Rahman; D A Anwar Al Aman; Nurul I Setu; Rebecca Banoo; Mohammad A Rashid
Journal:  Front Chem       Date:  2017-04-28       Impact factor: 5.221

2.  Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics.

Authors:  Ana Santoveña-Estévez; Javier Suárez-González; Amor R Cáceres-Pérez; Zuleima Ruiz-Noda; Sara Machado-Rodríguez; Magdalena Echezarreta; Mabel Soriano; José B Fariña
Journal:  Pharmaceutics       Date:  2020-02-24       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.